Skip to main content
Download PDF

Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’

Trials volume 17, Article number: 465 (2016) Cite this article

The Original Article was published on 16 July 2016

Erratum

Unfortunately, the original version of this article [1] contained an error. There are two references in the text to the threshold for defining VAP as greater than 10^4 colony forming units/ml. These should read greater OR EQUAL to 10^4 colony forming units/ml. The error is in the abstract and in the intervention sections.

In the abstract, please replace:

Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [>]104 colony forming units per millilitre (CFU/ml).

With the following correct version:

Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [≥]104 colony forming units per millilitre (CFU/ml).

In the Interventions, please replace:

VAP is confirmed by the widely used threshold of growth of a potential pathogen at [>]104 colony forming units per ml (CFU/ml)(13).

With the following correct version:

VAP is confirmed by the widely used threshold of growth of a potential pathogen at [≥]104 colony forming units per ml (CFU/ml)(13).

Reference

  1. Hellyer TP, Anderson NH, Jennie P, Paul D, Tina Van Den B, Suveer S, Ronan MM, Agus AM, Emerson LM, Bronagh B, Savita G, Walsh TS, Perkins GD, Conway Morris A, McAuley DF, Simpson AJ. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial. Trials. 2016;17:318.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

    Thomas P. Hellyer & A. John Simpson

  2. Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK

    Niall H. Anderson & Daniel F. McAuley

  3. Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK

    Jennie Parker

  4. Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre & Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK

    Paul Dark

  5. Becton Dickinson Biosciences, Erembodegem, Aalst, Belgium

    Tina Van Den Broeck

  6. Intensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK

    Suveer Singh

  7. Department of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK

    Ronan McMullan

  8. Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK

    Ashley M. Agus & Daniel F. McAuley

  9. Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK

    Lydia M. Emerson & Bronagh Blackwood

  10. Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK

    Savita Gossain

  11. MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK

    Tim S. Walsh

  12. University of Warwick and Heart of England NHS Foundation Trust, Coventry, UK

    Gavin D. Perkins

  13. Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge Biomedical Campus, Cambridge, UK

    Andrew Conway Morris

  14. Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK

    Daniel F. McAuley

Authors
  1. Thomas P. Hellyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niall H. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennie Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Dark
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tina Van Den Broeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suveer Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ronan McMullan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ashley M. Agus
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lydia M. Emerson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bronagh Blackwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Savita Gossain
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tim S. Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Gavin D. Perkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Andrew Conway Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Daniel F. McAuley
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. A. John Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas P. Hellyer.

Additional information

The online version of the original article can be found under doi:10.1186/s13063-016-1442-x.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hellyer, T.P., Anderson, N.H., Parker, J. et al. Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’. Trials 17, 465 (2016). https://doi.org/10.1186/s13063-016-1594-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13063-016-1594-8

Trials

ISSN: 1745-6215